INTRODUCTION
============

Large-conductance Ca^2+^-activated K^+^ (BK~Ca~) channels are expressed in a wide variety of cell types and consist of pore-forming α subunits and auxiliary β1--4 subunits that modify channel function ([@bib17]). In arterial smooth muscle cells, β1 subunits are the principal molecular and functional BK~Ca~ channel auxiliary subunit isoform ([@bib4]; [@bib26]). Arterial smooth muscle cell BK~Ca~ channel activation causes membrane hyperpolarization, leading to a reduction in voltage-dependent Ca^2+^ channel activity, a decrease in intracellular Ca^2+^ concentration (\[Ca^2+^\]~i~), and vasodilation ([@bib7]; [@bib12]). In contrast, BK~Ca~ channel inhibition causes membrane depolarization, which activates voltage-dependent Ca^2+^ channels, leading to an \[Ca^2+^\]~i~ elevation and vasoconstriction.

Global cytosolic \[Ca^2+^\]~i~ is typically 100--300 nM, whereas BK~Ca~ channels are sensitive to micromolar \[Ca^2+^\]~i~ ([@bib12]; [@bib25]). In arterial smooth muscle cells, BK~Ca~ channels are activated by localized micromolar \[Ca^2+^\]~i~ transients termed Ca^2+^ sparks ([@bib22]; [@bib12]). Ca^2+^ sparks are generated by the concerted opening of several SR ryanodine-sensitive Ca^2+^ release (RYR) channels ([@bib22]; [@bib12]). Ca^2+^ spark--induced BK~Ca~ currents induce membrane hyperpolarization and vasodilation.

SR inositol 1,4,5-trisphosphate (IP~3~)-gated Ca^2+^ release channels are also expressed in many different cell types, including arterial smooth muscle ([@bib31]; [@bib21]; [@bib10]; [@bib36]; [@bib37]). In native and cultured vascular smooth muscle cells, IP~3~ receptor (IP~3~R) activation stimulates propagating intracellular Ca^2+^ waves and elevates global \[Ca^2+^\]~i~ ([@bib16]; [@bib15]; [@bib33]; [@bib36]). Three different IP~3~R isoforms (1--3) have been identified, each of which is encoded by a different gene ([@bib28]; [@bib3]). Type 1 IP~3~Rs are the principal molecular and functional IP~3~R isoform mediating agonist and IP~3~-induced intracellular Ca^2+^ signals in aortic and cerebral artery smooth muscle cells ([@bib36]; [@bib37]). IP~3~R2 also contributes to acetylcholine-induced Ca^2+^ oscillations in cultured portal vein smooth muscle cells ([@bib21]). IP~3~R1 activation stimulates propagating intracellular Ca^2+^ waves and causes an increase in global \[Ca^2+^\]~i~ ([@bib36]). IP~3~R1 activation also stimulates a nonselective cation current (I~Cat~) via an SR Ca^2+^ release--independent mechanism in cerebral artery smooth muscle cells ([@bib34]; [@bib36]). This cation current occurs due to physical coupling of IP~3~R1 to TRPC3 channels, is primarily due to Na^+^ influx, and leads to membrane depolarization, voltage-dependent Ca^2+^ channel activation, and a global \[Ca^2+^\]~i~ elevation ([@bib34]; [@bib1]). IP~3~R1-mediated SR Ca^2+^ release and TRPC3 channel activation both elevate \[Ca^2+^\]~i~, leading to vasoconstriction ([@bib34]; [@bib36]).

IP~3~R-mediated SR Ca^2+^ release activates BK~Ca~ channels in basilar artery smooth muscle cells ([@bib13]). Given that IP~3~Rs directly activate nearby TRPC3 channels in arterial smooth muscle cells ([@bib34]; [@bib36]; [@bib1]), we studied the mechanisms by which IP~3~ and IP~3~Rs modulate BK~Ca~ channels. We tested the hypothesis that IP~3~ activates BK~Ca~ channels via an SR Ca^2+^ release--independent mechanism. Our data indicate that IP~3~ activates BK~Ca~ channels both in intact cells and excised membrane patches where SR Ca^2+^ release cannot occur. IP~3~ elevated BK~Ca~ channel apparent Ca^2+^ sensitivity, required IP~3~R1 activation, and was absent in IP~3~R1-deficient (IP~3~R1^−/−^) cells. Our data also indicate that IP~3~R1 is located in close spatial proximity to BK~Ca~ channels and coimmunoprecipitates with BK~Ca~ channel α and β1 subunits. This study identifies a novel signaling mechanism whereby IP~3~R1 activation stimulates nearby BK~Ca~ channels. Since IP~3~Rs and BK~Ca~ channels are broadly expressed, this coupling mechanism may exist in a wide variety of different cell types.

MATERIALS AND METHODS
=====================

Tissue preparation and cell isolation
-------------------------------------

All animal protocols were reviewed and approved by the University of Tennessee Animal Care and Use Committee. Male Sprague-Dawley rats (6--8 wk) and wild-type and IP~3~R1^−/−^ mice (3 wk) were euthanized by intraperitoneal injection of 150 mg/kg sodium pentobarbital. Generation of the IP~3~R1 knockout mice will be described in a future publication. In brief, exon 5 of IP~3~R1 was flanked by two lox P sites, and IP~3~R1-floxed mice were generated by homologous recombination. IP~3~R1-floxed mice were subsequently crossed with protamine Cre mice ([@bib23]) to generate conventional IP~3~R1 knockout mice in which exon 5 is deleted globally and no IP~3~R1 protein can be detected (see [Fig. 5 A](#fig5){ref-type="fig"}). The phenotype of the global knockout IP~3~R1 mice generated is the same as that previously published for global loss of function of IP~3~R1 mice ([@bib19]). Brains were removed after the rats and mice were euthanized. Aorta was also collected from mice. Tissues were placed into ice-cold (4°C), oxygenated (21% O~2~, 5% CO~2~), physiological saline solution containing (in mM): 119 NaCl, 4.7 KCl, 24 NaHCO~3~, 1.2 KH~2~PO~4~, 1.6 CaCl~2~, 1.2 MgSO~4~, 0.023 EDTA, and 11 glucose. Posterior cerebral and cerebellar arteries (∼50--200 µm in diameter) were dissected from the brains and cleaned of connective tissue. Arterial smooth muscle cells were enzymatically dissociated from cerebral arteries as described previously, maintained at 4°C, and used within 8 h ([@bib6]). Mouse aorta was used only for Western blotting experiments.

Patch clamp electrophysiology
-----------------------------

Single BK~Ca~ channel currents were recorded in isolated cerebral artery smooth muscle cells using either the cell-attached or inside-out patch clamp configuration (Axopatch 200B and Clampex 8.2; MDS Analytical Technologies). For cell-attached patch, the pipette and bath solution contained (in mM): 130 KCl, 10 HEPES, 1 MgCl~2~, 5 EGTA, 1.6 HEDTA, and 10 µM free Ca^2+^, pH 7.2 with KOH. For inside-out patches, the same pipette and bath solutions were used, except for experiments measuring BK~Ca~ channel Ca^2+^ sensitivity, where free Ca^2+^ concentration was adjusted to between 1 and 300 µM by the addition of CaCl~2~ and free Mg^2+^ maintained at 1 mM by adjustment of MgCl~2~. Where indicated, equimolar EGTA was substituted for BAPTA, a fast Ca^2+^ chelator, in both the pipette and bath solutions. Free Ca^2+^ concentration in solutions was measured using a Ca^2+^-sensitive (no. 476041; Corning) and reference (no. 476370; Corning) electrode. Cell-attached and inside-out patch experiments were performed at membrane voltages of +60 and −40 mV, respectively. BK~Ca~ currents were filtered at 1 kHz and digitized at 5 kHz. Analysis was performed offline using Clampfit 9.2 (MDS Analytical Technologies).

Western blotting
----------------

Mouse aorta or rat cerebral artery proteins were separated using 7.5% SDS-polyacrylamide gels and transferred onto nitrocellulose membranes. Membranes were cut so that the same lysate could be probed for several different molecular weight proteins. Membranes were incubated with mouse monoclonal anti-IP~3~R1 (NeuroMab), mouse monoclonal anti--BK~Ca~ α (NeuroMab), or rabbit polyclonal anti--BK~Ca~ β1 (Abcam) primary antibodies overnight at 4°C in Tris-buffered solution (TBS) containing 0.1% Tween 20 (TBS-T) and 5% nonfat dry milk. After washing with TBS-T, membranes were incubated with horseradish peroxidase--conjugated secondary antibodies, followed by washing with TBS-T. Membranes were then developed using enhanced chemiluminescence (GE Healthcare), and digital images were obtained using a Kodak FX Pro imaging system.

Immunofluorescence resonance energy transfer (immuno-FRET)
----------------------------------------------------------

Isolated cells were allowed to adhere to poly-L-lysine--coated coverslips. Cells were then fixed with 3.7% paraformaldehyde, permeabilized with 0.1% Triton X-100, and treated with the following primary antibodies: mouse monoclonal anti-IP~3~R1 (clone L24/18; NeuroMab) and either rabbit polyclonal anti-BK~Ca~α (Abcam) or rabbit polyclonal anti-TRPM4 (Thermo Fisher Scientific), each at a dilution of 1:100. After washing, cells were incubated with the following secondary antibodies: Cy3-conjugated donkey anti--mouse for IP~3~R1 (Jackson ImmunoResearch Laboratories, Inc.) and Cy2-conjugated goat anti--rabbit (Jackson ImmunoResearch Laboratories, Inc.) for BK~Ca~α or TRPM4. After washing, coverslips were dried and mounted onto glass slides. Fluorescence images were acquired using a laser-scanning confocal microscope (LSM Pascal; Carl Zeiss, Inc.). Cy2 and Cy3 were excited at 488 and 543 nm, and emission was collected at 505--530 and ≥560 nm, respectively. Negative controls were prepared by omitting primary antibodies. Images were background-subtracted, and N-FRET was calculated on a pixel-by-pixel basis for the entire image and in regions of interest (within the boundaries of the cell) using the Xia method ([@bib35]) and LSM FRET Macro tool (v2.5; Carl Zeiss, Inc.).

Coimmunoprecipitation (coIP)
----------------------------

Arterial lysate was harvested from cerebral arteries pooled from ∼15 rats using ice-cold lysis buffer (Thermo Fisher Scientific), giving ∼1.5 mg of total protein. coIP was done using the Thermo Fisher Scientific Co-Immunoprecipitation kit. The IP~3~R1 antibody was first immobilized for 2 h using coupling resin (AminoLink Plus; Thermo Fisher Scientific). The resin was then washed and incubated with arterial lysate overnight. After incubation, the resin was again washed and protein was eluted using elution buffer. Non-denaturing sample buffer (Thermo Fisher Scientific) was added to the eluate and boiled. Negative controls received the same treatment, except that the coupling resin was replaced with control agarose resin that is not amine-reactive. Samples were analyzed using Western blotting with mouse monoclonal anti-IP~3~R1, mouse monoclonal anti--BK~Ca~ α, or rabbit polyclonal anti--BK~Ca~ β1 primary antibodies, and horseradish peroxidase--conjugated secondary antibodies.

Statistical analysis
--------------------

BK~Ca~ channel activity (NP~o~) was calculated from continuous gap-free data using the following equation: NP~o~ = Σ (t~1~ + t~2~...t~i~), where t~i~ is the relative open time (time open/total time) for each channel level. Open probability (P~o~) was calculated by dividing NP~o~ by channel number (N). The total number of channels in inside-out patches was determined by introducing 1 mM of free Ca^2+^ into the bath solution at the end of each experiment. BK~Ca~ channel IP~3~ sensitivity data and relationships between BK~Ca~ channel open probability (P~o~) and free Ca^2+^ concentration were fit with a Boltzmann function: Y = P~o~min + \[(P~o~max−P~o~min)/(1+exp\[(*K*~d~-X)/slope\])\]. Values are expressed as mean ± SE. Student's *t* test and repeated measures analysis of variance with Student-Newman-Keuls post-hoc test were used for comparing paired or unpaired data and multiple datasets, as appropriate. P \< 0.05 was considered significant.

Online supplemental material
----------------------------

Data in Fig. S1 demonstrate that antigenic peptides abolish fluorescent labeling by BK~Ca~ channel α and TRPM4 channel antibodies. Also shown are differential interference contrast images of the same cells imaged for fluorescence. Fig. S1 is available at <http://www.jgp.org/cgi/content/full/jgp.201010453/DC1>.

RESULTS
=======

IP~3~ activates BK~Ca~ channels in cerebral artery smooth muscle cells
----------------------------------------------------------------------

BK~Ca~ channel regulation by IP~3~ was first measured in intact arterial smooth muscle cells using the cell-attached configuration of the patch clamp technique. Bt-IP~3~, a membrane-permeant IP~3~ analogue, at concentrations of 10 and 50 µM, increased mean BK~Ca~ channel activity (NP~o~) ∼1.8- and 1.9-fold, respectively, at +60 mV ([Fig. 1, A and B](#fig1){ref-type="fig"}).

![IP~3~ activates BK~Ca~ channels in cerebral artery smooth muscle cells. (A) Original recordings obtained from the same cell illustrating activation of BK~Ca~ channel by Bt-IP~3~ at +60 mV. (B) Mean data (*n*: control, 5; 10 µM Bt-IP~3~, 5; 50 µM Bt-IP~3~, 5). \*, P \< 0.05.](JGP_201010453_LW_Fig1){#fig1}

Next, we investigated whether IP~3~ has effects on BK~Ca~ channels that are independent of plasma membrane Ca^2+^ influx or intracellular Ca^2+^ release. BK~Ca~ channel regulation was studied in excised inside-out membrane patches at a physiological steady membrane voltage of −40 mV, which is similar to that of cerebral arteries pressurized to 60 mmHg ([@bib14]). In inside-out patches exposed to symmetrical 10 µM of free \[Ca^2+^\]~i~, 10 µM IP~3~ increased mean BK~Ca~ channel open probability (P~o~) from ∼0.24 to 0.37, or 1.54-fold ([Fig. 2, A and B](#fig2){ref-type="fig"}). In contrast, IP~3~ did not alter single BK~Ca~ channel amplitude (pA: control, 8.5 ± 0.47; IP~3~, 8.0 ± 0.36; *n* = 5; P \> 0.05; [Fig. 2 A](#fig2){ref-type="fig"}). IP~3~ also caused concentration-dependent BK~Ca~ channel activation ([Fig. 2 B](#fig2){ref-type="fig"}). Fitting an IP~3~ concentration--response curve with a Boltzmann function indicated that IP~3~ increased BK~Ca~ channel P~o~ with an apparent *K*~d~ of ∼4.1 µM, a slope of ∼2.8, and a maximal P~o~ of ∼0.38 ([Fig. 2 B](#fig2){ref-type="fig"}). IP~3~ activated BK~Ca~ channels in excised patches for as long as the seal could be maintained (\>30 min), indicating that SR Ca^2+^ release was unlikely to be responsible for channel activation. In support of this concept, equimolar substitution of bath and pipette EGTA for BAPTA, a fast Ca^2+^ chelator, did not alter IP~3~-induced BK~Ca~ channel activation ([Fig. 2 C](#fig2){ref-type="fig"}). Elevating pipette free Ca^2+^ from 10 µM to 2 mM also did not alter IP~3~-induced BK~Ca~ channel activation, indicating that plasma membrane Ca^2+^ influx was not responsible for channel activation ([Fig. 2 C](#fig2){ref-type="fig"}). Collectively, these data indicate that IP~3~ activates BK~Ca~ channels via an SR Ca^2+^ release--independent mechanism.

![IP~3~ activates BK~Ca~ channels in excised inside-out membrane patches. (A) Original recordings from the same inside-out patch illustrating concentration-dependent BK~Ca~ channel activation by IP~3~ at −40 mV. (B) Mean data fit with a Boltzmann function. IP~3~ increased BK~Ca~ channel P~o~ with an apparent *K*~d~ of 4.1 ± 1.3 µM, a slope of 2.8 ± 1.9, and a maximal P~o~ of 0.38 ± 0.02. Experimental numbers are (\[IP~3~\]): 0.01 µM, 4; 0.1 µM, 4; 1 µM, 4; 3 µM, 5; 10 µM, 5; 30 µM, 5. (C) Mean data illustrating that buffering Ca^2+^ with BAPTA or elevating pipette (extracellular) Ca^2+^ from 10 µM to 2 mM does not alter IP~3~ (10 µM)-induced BK~Ca~ channel activation (*n*: 10 µM \[Ca^2+^\]~o~/10 µM \[Ca^2+^\]~i~ (EGTA/EGTA); control, 4; IP~3~, 4; 10 µM \[Ca^2+^\]~o~/10 µM \[Ca^2+^\]~i~ (BAPTA/BAPTA); control, 4; IP~3~, 4; 2 mM \[Ca^2+^\]~o~/10 µM \[Ca^2+^\]~i~ (none/EGTA) control, 3; IP~3~, 3). \*, P \< 0.05.](JGP_201010453_LW_Fig2){#fig2}

IP~3~ elevates BK~Ca~ channel apparent Ca^2+^ sensitivity
---------------------------------------------------------

IP~3~ regulation of BK~Ca~ channel apparent Ca^2+^ sensitivity was examined at a steady membrane voltage of −40 mV. In control, mean apparent *K*~d~ for Ca^2+^ was ∼20 µM, with a slope of ∼1.2, and a maximum P~o~ of ∼0.82 ([Fig. 3 A](#fig3){ref-type="fig"}). In the same membrane patches, 10 µM IP~3~ decreased the mean *K*~d~ for Ca^2+^ to ∼12 µM, but did not alter the slope or the maximum P~o~ ([Fig. 3 A](#fig3){ref-type="fig"}). Relative activation by IP~3~ increased considerably between 1 and 10 µM Ca^2+^ ([Fig. 3 B](#fig3){ref-type="fig"}). For example, with 1 µM of free Ca^2+^, IP~3~ increased mean BK~Ca~ channel P~o~ 1.14-fold, whereas with 10 µM of free Ca^2+^, IP~3~ increased mean P~o~ 1.48-fold ([Fig. 3 B](#fig3){ref-type="fig"}). At free \[Ca^2+^\] \>10 µM, relative activation by IP~3~ became smaller because channel activity was approaching maximal. These data suggest that IP~3~ elevates BK~Ca~ channel apparent Ca^2+^ sensitivity in arterial smooth muscle cells.

![IP~3~ elevates BK~Ca~ channel apparent Ca^2+^ sensitivity. (A) Mean data illustrating IP~3~-induced BK~Ca~ channel activation over a range of free Ca^2+^ concentrations in inside-out patches at −40 mV. Data are fit with a Boltzmann function constrained to ≥0. Experimental numbers are given after each \[Ca^2+^\] (µM): control: 1, 8; 3, 6; 10, 6; 30, 6; 100, 8; 300, 8; 10 µM IP~3~: 1, 7; 3, 6; 10, 6; 30, 6; 100, 7; 300, 7. (B) Mean data illustrating IP~3~-induced change in BK~Ca~ channel P~o~ at each \[Ca^2+^\]. Data are fit with a Gaussian function. In control, the *K*~d~ for Ca^2+^ was 20.4 ± 0.9 µM, a slope of 1.2 ± 0.2, and a maximum P~o~ of 0.82 ± 0.04. 10 µM IP~3~ decreased the mean *K*~d~ for Ca^2+^ to 12.4 ± 0.8 µM (P \< 0.05), but did not alter the slope (1.3 ± 0.3) or the maximum P~o~ (0.83 ± 0.03; P \> 0.05 for each).](JGP_201010453_LW_Fig3){#fig3}

IP~3~R1 activation mediates IP~3~-induced BK~Ca~ channel activation
-------------------------------------------------------------------

To identify mechanisms by which IP~3~ activates BK~Ca~ channels, we tested the hypothesis that IP~3~Rs mediate IP~3~-induced BK~Ca~ channel activation. In inside-out patches, 1 mg/ml heparin, an IP~3~R blocker, reversed BK~Ca~ channel activation by IP~3~ ([Fig. 4 A](#fig4){ref-type="fig"}). In contrast, 1 mg/ml heparin alone did not alter mean BK~Ca~ channel P~o~ (98.9 ± 12.5% of control; *n* = 5; P \> 0.05). These data indicate that IP~3~-induced IP~3~R activation stimulates BK~Ca~ channels.

![IP~3~R1 mediates IP~3~-induced BK~Ca~ channel activation. (A) Mean data illustrating that heparin reverses IP~3~-induced BK~Ca~ channel activation (*n*: control (10 µM Ca^2+^), 5; 30 µM IP~3~, 5; 30 µM IP~3~ plus 1 mg/ml heparin, 5). (B) Original recording from the same inside-out patch illustrating control BK~Ca~ channel activity (i), IP~3~ (30 µM)-induced channel activation (ii), reversal by monoclonal IP~3~R1 antibody (iii, 1:100; clone L24/18; NeuroMab), and no further effect of heparin applied in the continued presence of IP~3~R1 antibody (iv). (C) Mean data illustrating that monoclonal IP~3~R1 antibody inhibits IP~3~-induced BK~Ca~ channel activation, and that the addition of heparin leads to no further change in activity (control (10 µM Ca^2+^), *n* = 4; 30 µM IP~3~, *n* = 4; 30 µM IP~3~ plus IP~3~R1 antibody (1:100), *n* = 4; 30 µM IP~3~ plus IP~3~R1 antibody (1:100), *n* = 4; 30 µM IP~3~ plus IP~3~R1 antibody (1:100) plus heparin, *n* = 4; IP~3~ plus boiled IP~3~R1 antibody, *n* = 4). (D) Mean data illustrating that adenophostin A activates BK~Ca~ channels (*n*: control (10 µM Ca^2+^), 4; 1 µM adenophostin A, 4). \*, P \< 0.05.](JGP_201010453_LW_Fig4){#fig4}

Type 1 IP~3~Rs are the principal molecular isoform expressed in cerebral artery and aortic smooth muscle cells ([@bib36]; [@bib37]; [@bib1]). Therefore, we studied whether IP~3~R1 mediates IP~3~-induced BK~Ca~ channel activation. In inside-out patches, a monoclonal IP~3~R1 antibody (1:100) reversed IP~3~-induced BK~Ca~ channel activation ([Fig. 4, B and C](#fig4){ref-type="fig"}). In contrast, the IP~3~R1 antibody (1:100) did not alter mean BK~Ca~ channel activity when applied alone (94.2 ± 4.9% of control; *n* = 4; P \> 0.05). The addition of heparin in the presence of IP~3~ plus IP~3~R1 antibody did not cause any further reduction in BK~Ca~ channel P~o~ ([Fig. 4, B and C](#fig4){ref-type="fig"}). Boiled (95°C for 15 min) IP~3~R1 antibody did not alter IP~3~-induced BK~Ca~ channel activation ([Fig. 4 C](#fig4){ref-type="fig"}). To further examine BK~Ca~ channel regulation by IP~3~Rs, we used adenophostin A as an alternate IP~3~R agonist. 1 µM adenophostin A increased BK~Ca~ channel activity ∼1.60-fold ([Fig. 4 D](#fig4){ref-type="fig"}). These data indicate that IP~3~R1 activation is necessary for IP~3~-mediated BK~Ca~ channel activation in arterial smooth muscle cells.

To further investigate the necessity for IP~3~R1 and to determine whether IP~3~-induced BK~Ca~ channel activation occurs in another species, we studied BK~Ca~ channel regulation in mouse wild-type (IP~3~R1^+/+^) and IP~3~R1 knockout (IP~3~R1^−/−^) cerebral artery smooth muscle cells. Western blotting confirmed that IP~3~R1 was present in IP~3~R1^+/+^ mouse aorta, but absent in IP~3~R1^−/−^ mouse aorta ([Fig. 5 A](#fig5){ref-type="fig"}). BK~Ca~ channel P~o~ (IP~3~R1^+/+^, 0.30 ± 0.08; IP~3~R1^−/−^, 0.27 ± 0.03; *n* = 5) and amplitude (pA: IP~3~R1^+/+^, 10.2 ± 0.8; IP~3~R1^−/−^, 11.4 ± 0.8; *n* = 5) were similar in inside-out patches from IP~3~R1^+/+^ and IP~3~R1^−/−^ cerebral artery smooth muscle cells exposed to 10 µM Ca^2+^ (P \> 0.05 for each). IP~3~ increased mean BK~Ca~ channel P~o~ to ∼142% of control in inside-out patches from mouse IP~3~R1^+/+^ cells ([Fig. 5 B](#fig5){ref-type="fig"}). Furthermore, in patches from IP~3~R1^+/+^ cells, IP~3~-induced BK~Ca~ channel activation was reversed by heparin ([Fig. 5 B](#fig5){ref-type="fig"}). In contrast, IP~3~ or IP~3~ plus heparin did not alter BK~Ca~ channel P~o~ in excised patches from IP~3~R1^−/−^ arterial smooth muscle cells ([Fig. 5 B](#fig5){ref-type="fig"}). These data indicate that IP~3~R1 is essential for IP~3~-induced BK~Ca~ channel activation in cerebral artery smooth muscle cells.

![Genetic ablation of IP~3~R1 abolishes IP~3~-induced BK~Ca~ channel activation in cerebral artery smooth muscle cells. (A) Western blot indicating that IP~3~R1 protein (∼270 kD) is present in IP~3~R1^+/+^ mouse aorta and absent in IP~3~R1^−/−^ aorta. (B) Mean data illustrating that 10 µM IP~3~ activates BK~Ca~ channels in inside-out patches from mouse IP~3~R1^+/+^ cerebral artery smooth muscle cells, but not in mouse IP~3~R1^−/−^ cerebral artery smooth muscle cells. Mean data also indicate that 1 mg/ml heparin reverses IP~3~-induced BK~Ca~ channel activation in IP~3~R1^+/+^ cells. Membrane voltage was −40 mV. IP~3~R1^−/−^: control, *n* = 5; IP~3~, *n* = 5; IP~3~ plus heparin, *n* = 5. IP~3~R1^+/+^: control, *n* = 5; IP~3~, *n* = 5; IP~3~ plus heparin, *n* = 5. \*, P \< 0.05.](JGP_201010453_GS_Fig5){#fig5}

BK~Ca~ channel α subunits colocalize with IP~3~R1
-------------------------------------------------

Our data indicate that IP~3~R1 and BK~Ca~ channels functionally interact. Therefore, spatial localization of these proteins was studied using immuno-FRET microscopy. Cy2- and Cy3-tagged secondary antibodies targeting primary antibodies bound to IP~3~R1 and BK~Ca~ channel α subunits, respectively, generated whole cell N-FRET of 20.4 ± 1.3% (*n* = 11; [Fig. 6 A](#fig6){ref-type="fig"}). In contrast, whole cell N-FRET between IP~3~R1 and TRPM4 channels, which do not colocalize in cerebral artery smooth muscle cells ([@bib1]), was significantly lower at 7.4 ± 1.0% (*n* = 10; P \> 0.05; [Fig. 6 A](#fig6){ref-type="fig"}). N-FRET between IP~3~R1 and BK~Ca~ channels was observed both at the plasma membrane and intracellularly. Antigenic peptides abolished fluorescent labeling by BK~Ca~ and TRPM4 channel antibodies, respectively ([Fig. S1](http://www.jgp.org/cgi/content/full/jgp.201010453/DC1)). An antigenic peptide was not available for the monoclonal IP~3~R1 antibody, but this antibody detects only IP~3~R1 protein in a Western blot, indicating selectivity ([@bib1]). These data indicate that IP~3~R1 is located in close proximity to plasma membrane BK~Ca~ channels in arterial smooth muscle cells.

![BK~Ca~ channel subunits are located in close spatial proximity to IP~3~R1 in cerebral artery smooth muscle cells. (A) Immuno-FRET data illustrating close spatial proximity of IP~3~R1 to BK~Ca~ channel α subunits. Cy2- and Cy3-labeled secondary antibodies bound to IP~3~R1 and BK~Ca~ channels generate N-FRET. In contrast, secondary antibodies bound to IP~3~R1 and TRPM4 do not generate significant N-FRET. Bars, 10 µm. (B) Monoclonal IP~3~R1 antibody coimmunoprecipitates IP~3~R1 (∼270 kD), BK~Ca~ channel α (∼125 kD), and β1 (∼36 kD) subunits from cerebral arteries. Lysate supernatant was used as the input (+ve) control. Beads that have no antibody-binding capacity were used in the negative (−ve) coIP control.](JGP_201010453R_RGB_Fig6){#fig6}

BK~Ca~ channel α and β1 subunits coimmunoprecipitate with IP~3~R1
-----------------------------------------------------------------

coIP was performed to test the hypothesis that IP~3~R1 and BK~Ca~ channels are contained within the same macromolecular protein complex. Due to the small size of the resistance (100--200-µm diameter), cerebral arteries used in this study, arteries collected from ∼15 rats, were required for each coIP experiment. The monoclonal IP~3~R1 antibody coimmunoprecipitated IP~3~R1 with BK~Ca~ channel α and β1 subunits from cerebral artery lysate ([Fig. 6 B](#fig6){ref-type="fig"}). These data indicate that IP~3~R1 and BK~Ca~ channels are located within the same macromolecular complex in arterial smooth muscle cells.

DISCUSSION
==========

Here, we demonstrate that IP~3~-induced IP~3~R1 activation stimulates BK~Ca~ channels via a local SR Ca^2+^ release--independent coupling mechanism in cerebral artery smooth muscle cells. Novel findings are that: (a) IP~3~ activates BK~Ca~ channels in excised membrane patches removed from cytosolic signaling pathways; (b) IP~3~ elevates BK~Ca~ channel apparent Ca^2+^ sensitivity; (c) IP~3~R1 expression and activation are required for IP~3~ to stimulate BK~Ca~ channels; and (d) IP~3~R1 and BK~Ca~ channel subunits are located in close spatial proximity and coimmunoprecipitate. These data identify a novel signaling mechanism whereby IP~3~R1 channels activate plasma membrane BK~Ca~ channels via an SR Ca^2+^ release--independent local coupling mechanism in arterial smooth muscle cells. Given that both IP~3~Rs and K~Ca~ channels are widely expressed, such communication may occur in other cell types.

Agonist binding to PLC-coupled receptors leads to phosphatidylinositol 4,5-bisphosphate cleavage and an elevation in both diacyglycerol and IP~3~ in smooth muscle cells. Diacyglycerol remains membrane bound and stimulates PKC, which phosphorylates a wide variety of target proteins that regulate contractility, including ion channels and the contractile apparatus ([@bib7]; [@bib12]). Relevant to this study, PKC inhibits arterial smooth muscle cell BK~Ca~ channels, leading to membrane depolarization and vasoconstriction ([@bib7]; [@bib12]). Arteries undergo steady-state changes in membrane potential, with a dynamic range between ∼−60 and −20 mV ([@bib14]; [@bib7]). Here, BK~Ca~ channel regulation was studied primarily at a steady voltage of −40 mV, which is the membrane potential of cerebral arteries at a physiological intravascular pressure of 60 mmHg ([@bib14]). IP~3~ activated BK~Ca~ channels in both intact cells and in excised membrane patches. In excised patches, IP~3~ increased BK~Ca~ channel activity with an apparent *K*~d~ of ∼4 µM. Previous studies have estimated global intracellular IP~3~ concentration (\[IP~3~\]~i~) to be 0.1--3 µM in unstimulated cells and 1--20 µM in agonist-stimulated cells ([@bib9]; [@bib18]; [@bib29]; [@bib24]). Recent studies using fluorescent IP~3~ biosensors suggested that receptor agonists elevate global \[IP~3~\]~i~ to ∼30 nM in cardiac myocytes and up to 700 nM in COS-7 and HSY-EA1 cells ([@bib27]; [@bib30]). In arterial myocytes, global \[IP~3~\]~i~ is unclear, but local IP~3~ gradients higher than global \[IP~3~\]~i~ should exist, particularly within the immediate vicinity of PLC where IP~3~ is generated. The \[IP~3~\]~i~ nearby a target protein such as an IP~3~R will depend on many factors, including PLC activity, proximity of IP~3~Rs to PLC, and IP~3~ metabolism. K~Ca~ channel IP~3~ sensitivity determined here may indicate IP~3~ concentrations that would occur nearby IP~3~Rs that are located in close proximity to plasma membrane BK~Ca~ channels.

IP~3~ acts primarily by relieving Ca^2+^ inhibition of IP~3~Rs, thereby permitting Ca^2+^-induced channel activation ([@bib31]; [@bib10]). Physiological micromolar \[Ca^2+^\]~i~ concentrations used here to study K~Ca~ channel activity would be expected to attenuate IP~3~-induced IP~3~R activation and may provide one explanation for the micromolar IP~3~ sensitivity of BK~Ca~ channel activation. IP~3~R IP~3~ sensitivity can also vary widely from nanomolar to micromolar depending on multiple factors in addition to \[Ca^2+^\]~i~, including IP~3~R isoform, splice variation, which can occur in many regions of the protein including the IP~3~-binding domain, and potentially through isoform heterotetramerization ([@bib31]; [@bib10]). For example, canine cerebellar IP~3~R1 is sensitive to IP~3~ over a broad concentration range and exhibits high (nM) and low (10 µM) affinity IP~3~-binding sites. The IP~3~ and Ca^2+^ sensitivity of arterial smooth muscle cell IP~3~Rs has not been determined, nor have these channels been cloned. Therefore, deriving mechanistic details regarding IP~3~R communication with K~Ca~ channels is difficult until detailed knowledge of smooth muscle cell IP~3~Rs is available, particularly IP~3~ and Ca^2+^ sensitivity. Our data indicate that under physiological voltage and local \[Ca^2+^\]~i~, micromolar \[IP~3~\]~i~ is required for IP~3~Rs to activate BK~Ca~ channels.

Data indicate that IP~3~ does not directly activate BK~Ca~ channels. Rather, IP~3~R1 mediates IP~3~-induced BK~Ca~ channel activation. This conclusion is supported by our observation that heparin, an IP~3~R1 antibody, and IP~3~R1 ablation all blocked IP~3~-induced BK~Ca~ channel activation. These data also indicate that functional IP~3~R1 protein is excised together with BK~Ca~ channels in inside-out patches. The Förster distance between Cy2 and Cy3 is 5--6 nm. If Cy2 and Cy3 are located in such local proximity, nonradiative dipole--dipole coupling between excited Cy2 (donor) and Cy3 (acceptor) leads to Cy3 emission. Thus, for FRET to occur, IP~3~R1 must be located in very close spatial proximity to BK~Ca~ channels. Supporting local interaction between these proteins, coIP data indicated that IP~3~R1 and BK~Ca~ channel α and β1 subunits were located in the same macromolecular complex. In contrast to FRET data indicating close spatial proximity of IP~3~R1 and BK~Ca~ channels, immuno-FRET data indicated that IP~3~R1 and TRPM4 channels are not spatially localized in arterial smooth muscle cells, in agreement with a recent report ([@bib1]). BK~Ca~ channels are also located nearby IP~3~Rs in cultured glioma cells, but in contrast to the observations made here, glioma cell IP~3~Rs activate BK~Ca~ channels via Ca^2+^ signaling and direct molecular coupling is absent ([@bib32]). Electron microscopy studies have shown that the SR and plasma membranes can be located in very close proximity (∼20 nm) in arterial smooth muscle cells ([@bib8]). Conceivably, IP~3~R1 and BK~Ca~ channels may be present within macromolecular complexes that bridge the SR and plasma membranes, allowing local molecular communication between these proteins. Immuno-FRET between IP~3~R1 and BK~Ca~ channel α subunits was observed both at the plasma membrane and intracellularly. The physiological function of close localization between IP~3~R1 and intracellular BK~Ca~ channels is unclear. Conceivably, BK~Ca~ channels may be contained within the SR or Golgi before membrane trafficking, and intracellular FRET may reflect the close proximity of these intracellular BK~Ca~ channels to IP~3~R1 located on the SR membrane. Alternatively, IP~3~R1 and BK~Ca~ channels may form into a protein complex before membrane trafficking.

Intact SR may have been excised within membrane patches, although SR Ca^2+^ would be depleted due to the recording conditions used (no ATP in bath solution). Furthermore, IP~3~ activated BK~Ca~ channels in patches that had been excised for \>30 min and in solutions that contained BAPTA, which would rapidly buffer any Ca^2+^ released by SR. Therefore, in inside-out patches studied here, IP~3~R-mediated SR Ca^2+^ release cannot underlie IP~3~-induced BK~Ca~ channel activation. Recently, we demonstrated that IP~3~R1 physically and functionally couples to TRPC3, but not TRPC6, channels in cerebral artery smooth muscle cells ([@bib1]). When considering previous observations and those made here, IP~3~R1, TRPC3, and BK~Ca~ channels may coassemble within a macromolecular complex that regulates Ca^2+^ signaling, membrane potential, and arterial contractility. Conceivably, IP~3~R-induced Ca^2+^ influx through plasma membrane TRPC3 channels could elevate submembrane \[Ca^2+^\]~i~ and activate nearby BK~Ca~ channels ([@bib1]). Several observations indicate that such a mechanism does not underlie IP~3~-induced BK~Ca~ channel activation reported here: (a) the driving force for Ca^2+^ influx (symmetrical 10 µM Ca^2+^) is weak and unlikely to sufficiently elevate \[Ca^2+^\]~i~ to activate BK~Ca~ channels; (b) BK~Ca~ channel activation occurred in the presence of BAPTA, which would rapidly buffer any entering Ca^2+^; and (c) elevating pipette free \[Ca^2+^\] to 2 mM did not alter IP~3~-induced BK~Ca~ channel activation. In intact cells with physiological Ca^2+^ buffers and cation gradients (i.e., 2 mM \[Ca^2+^\]~o~ and 100--300 nM \[Ca^2+^\]~i~), Ca^2+^ influx through TRPC3 channels may contribute to IP~3~R1-induced BK~Ca~ channel activation. However, TRPC3 channels are also Na^+^ permeant, and the larger driving force for Na^+^ influx would limit Ca^2+^ influx, reducing any potential Ca^2+^ signal to BK~Ca~ channels.

BK~Ca~ channels exhibited a micromolar *K*~d~ for Ca^2+^ similar to that previously determined in rat cerebral artery smooth muscle cells at the same voltage ([@bib25]). IP~3~ caused an elevation in BK~Ca~ channel apparent Ca^2+^ sensitivity with activation most prominent between 1 and 10 µM \[Ca^2+^\]~i~. These data indicate that IP~3~ will increase BK~Ca~ channel sensitivity to local micromolar Ca^2+^ gradients, but will not shift BK~Ca~ channel Ca^2+^ sensitivity into the global nanomolar \[Ca^2+^\]~i~ range. Data here and in a previous study indicate that IP~3~R1 activation both stimulates SR Ca^2+^ release and amplifies the sensitivity of nearby BK~Ca~ channels to micromolar \[Ca^2+^\]~i~ ([@bib36]). Therefore, the molecular coupling mechanism likely sensitizes BK~Ca~ channels to SR Ca^2+^ released from nearby IP~3~Rs.

When considering the physiological function of the local coupling mechanism between IP~3~R1 and BK~Ca~ channels, it is important to consider that PLC activation not only elevates IP~3~, but also stimulates PKC. PKC inhibits arterial smooth muscle cell BK~Ca~ channels both by reducing Ca^2+^ spark frequency and by direct BK~Ca~ channel inhibition ([@bib11]; [@bib12]). Thus, PKC reduces BK~Ca~ activation by RYR channels that generate Ca^2+^ sparks ([@bib12]). However, vasoconstrictors also activate Ca^2+^ waves and elevate global \[Ca^2+^\]~i~ ([@bib11]; [@bib20]; [@bib36]; [@bib1]). IP~3~R1 activation is essential for vasoconstrictor-induced Ca^2+^ waves and contributes to the global \[Ca^2+^\]~i~ elevation ([@bib36]). Collectively, these studies suggest that PLC-coupled receptor agonists shift control of BK~Ca~ channel activity from RYR channels to IP~3~Rs. IP~3~-induced BK~Ca~ channel activation would limit PKC-induced BK~Ca~ channel inhibition and attenuate the membrane depolarization and vasoconstriction.

The signaling mechanism by which IP~3~R1 elevates BK~Ca~ channel apparent Ca^2+^ sensitivity was not studied here. Several possibilities exist, including that an IP~3~-induced conformational change in IP~3~R1 may lead to direct interaction with either the BK~Ca~ channel α and/or β1 subunit. IP~3~R1 may also activate BK~Ca~ channels via an indirect interaction through intermediate proteins, including caveolin-1 ([@bib5]; [@bib2]). A deeper understanding of the molecular mechanisms by which IP~3~Rs stimulate BK~Ca~ channels will require further investigation.

In summary, data indicate that IP~3~-induced IP~3~R1 activation elevates BK~Ca~ channel apparent Ca^2+^ sensitivity through localized molecular coupling in arterial smooth muscle cells. This negative feedback mechanism would limit IP~3~-induced vasoconstriction in cerebral arteries. These data also raise the possibility that local communication between IP~3~Rs and BK~Ca~ channels may occur in a wide variety of cell types that express both of these proteins.
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